Yüklüyor......
Concomitant therapy with pioglitazone and insulin for the treatment of type 2 diabetes
To prevent hyperinsulinemia, which may cause atherosclerosis, thiazolidinediones (TZDs), also known as insulin sensitizers, are often added to the therapeutic regimen of patients with type 2 diabetes who are receiving insulin. The combination of insulin with pioglitazone, a TZD, reduces glycoated he...
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2010
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2856574/ https://ncbi.nlm.nih.gov/pubmed/20407626 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|